Epidemiology and Long-term Outcome of Patients With VHD

Coronary Artery Disease Clinical Trial

— BIA-WAD  

Official title:

Epidemiology and Long-term Prognosis of Patients With Valvular Heart Diseases (BIA-WAD Study)

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04527367
• Other study ID #: UMB-KKI-101
• Status: Completed
• Start date: January 2006
• Est. completion date: January 2022

Study information

• Verified date: December 2021
• Source: Medical University of Bialystok
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Valvular heart diseases are significant problem in Polish population. Coexistence of coronary artery disease in patients with VHD increases the risk of death and affects further therapeutic strategy. The aim of the study is analysis the epidemiology and the long-term prognosis among patients with VHD.

Description:

Valvular heart diseases are significant problem in Polish population. Coexistence of coronary artery disease in patients with VHD increases the risk of death and affects further therapeutic strategy.

Patients with moderate and severe valvular heart diseases are included into the study. The set of variables subject to interpretation consisted of demographic data, medical history, result of coronary angiography, and type of applied percutaneous and surgical treatment

Recruitment information / eligibility

• Status: Completed
• Enrollment: 2500
• Est. completion date: January 2022
• Est. primary completion date: January 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Valvular heart disease in moderate and severe stages

Exclusion Criteria:

• Age < 18 years old

Related Conditions & MeSH terms

• Aortic Valve Stenosis
• Chronic Kidney Diseases
• Constriction, Pathologic
• Coronary Artery Disease
• Coronary Disease
• Heart Diseases
• Heart Valve Diseases
• Kidney Diseases
• Mitral Insufficiency and Aortic Stenosis
• Mitral Stenosis
• Mitral Valve Insufficiency
• Mitral Valve Stenosis
• Myocardial Ischemia
• Renal Insufficiency, Chronic
• Valvular Disease
• Valvular Heart Disease

Intervention

Procedure:
• Innovative medical technologies in invasive cardiology and cardiac surgery
A follow-up study included the analysis of medical documentation of the Cardiosurgery and the Invasive Cardiology Departments to provided information on the duration and type of procedure performed.

Locations

Country	Name	City	State
Poland	Department of Invasive Cardiology, Medical University of Bialystok, The Medical University of Bialystok Clinical Hospital	Bialystok

Sponsors (1)

Lead Sponsor	Collaborator
Medical University of Bialystok

Country where clinical trial is conducted

Poland, 

References & Publications (2)

Kuzma L, Bachórzewska-Gajewska H, Kozuch M, Struniawski K, Pogorzelski S, Hirnle T, Dobrzycki S. Acute coronary syndromes and atherosclerotic plaque burden distribution in coronary arteries among patients with valvular heart disease (BIA-WAD registry). Po — View Citation

Kuzma L, Malyszko J, Bachórzewska-Gajewska H, Niwinska MM, Kurasz A, Zalewska-Adamiec M, Kozuch M, Dobrzycki S. Impact of chronic kidney disease on long-term outcome of patients with valvular heart defects. Int Urol Nephrol. 2020 Nov;52(11):2161-2170. doi — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Death	All-cause of mortality	3665 days
Secondary	MACCE	Mocardial infarction, stent thrombosis, stroke or transient ischemic attack, urgent revascularization	3665 days